Uplyftt Membership Program require to change account password.



*
*
*
 

Note:
Password should contains atleast one capital letter one lowercase letter and one symbol and number and must be atleast 8 characters in length.

US Generic Injectables Market Share, Size & Forecast Till 2026

  • According to the latest report by IMARC Group, titled “US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the US generic injectables market reached a value of US$ 13.7 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.8% during 2021-2026.

    We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

    Request Free Report Sample: https://www.imarcgroup.com/us-generic-injectables-market/requestsample

    Generic injectables are used as an alternative to innovator injectables without compromising the effectiveness of the treatment. They are available in the market only after the expiry of the innovator injectables. Generic injectables are extensively used for treating numerous life-threatening and chronic diseases such as cardiovascular diseases, respiratory diseases, diabetes, rheumatoid arthritis, cancer, osteoporosis and osteoarthritis. They are less expensive than their branded counterparts, thereby contributing in substantial savings for the patients and healthcare providers.

    The US generic injectables market is being driven by numerous favourable factors. Due to sedentary lifestyles, poor eating habits and ageing population, an increasing number of people are suffering from various chronic diseases. As the treatment of these diseases depends on the use of generic injectables for improved effectiveness and cost savings, this has facilitated the growth of the market. Moreover, several branded injectables worth billions of dollars are projected to lose their patent protection in the coming years. This is expected to provide ample opportunities to the generic manufacturers so as to expand their business. Further, the low cost of generic injectables makes them an affordable healthcare option, owing to which the US government is supporting the production of these drugs. Besides this, the low competition in the market results in increased profit margins for the manufacturers.

    US Generic Injectables Market 2021-2026 Competitive Analysis and Segmentation:

    Competitive Landscape With Key Players:

    The competitive landscape of the US generic injectables market has been studied in the report with the detailed profiles of the key players operating in the market.

    Key Market Segmentation:

    The report has segmented the US generic injectables market on the basis of therapeutic area, containers, distribution channel, end user and region.

    Breakup by Therapeutic Area:

    • Oncology
    • Anesthesia
    • Anti-infectives
    • Parenteral Nutrition
    • Cardiovascular

    Breakup by Containers:

    • Vials
    • Ampoules
    • Premix
    • Prefilled Syringes

    Breakup by Distribution Channel:

    • Hospitals
    • Retail Pharmacy

    Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/us-generic-injectables-market

    Key highlights of the report:            

    • Market Performance (2015-2020)
    • Market Outlook (2021-2026)
    • Industry Trends
    • Market Drivers and Success Factors
    • The Impact of COVID-19 on the Global Market
    • Value Chain Analysis
    • Structure of the Global Market
    • Comprehensive mapping of the competitive landscape

    If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

    About Us                                                                      

    IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

    IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

    Contact US

    IMARC Group

    30 N Gould St Ste R

    Sheridan, WY 82801 USA – Wyoming

    Email: Sales@imarcgroup.com

    Tel No:(D) +91 120 433 0800

    Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800